Skip to main content
. 2021 Nov;46(6):444–453. doi: 10.30476/ijms.2020.85872.1550

Table 1.

Comparisons of different demographic, clinical, and paraclinical data of the subjects between the case and control groups in the univariate model

Variables Case Group (n=50) Control Group (n=50) Univariate
P value OR (95% confidence interval)
Age (year) (mean±SD) 40.7±13.58 41.8±13.56 0.69 1.006 (0.97-1.03)
Sex (%) Male 32 (64) 32 (64) - 1
Female 18 (36) 18 (36) 1 1 (0.44-2.26)
Etiology (%) Others 32 (64) 29 (58) 1
Hypertension 18 (36) 21 (42) 0.54 0.78 (0.35-1.74)
Length of pre-transplantation dialysis (month, mean±SD) 15.0±12 17.5±12 0.56 0.99 (0.96-1.02)
Donor type (%) Cadaver 48 (96) 49 (98) - 1
Living 2 (4) 1 (2) 0.56 0.49 (0.04-5.58)
Donor age (year) (mean±SD) 36.38±14.18 36.14±15.19 0.34 1.01 (0.98-1.04)
Donor sex (%) Male 41 (82) 36 (72) - 1
Female 9 (18) 14 (28) 0.24 0.56 (0.22-1.46)
Cold ischemia time (hour), median (interquartile range) 5.13 (4.5) 7.7 (3.0) 0.98 0.99 (0.89-1.11)
Panel reactive antibody (%) Negative 44 (88) 47 (94) 1
Positive 6 (12) 3 (6) 0.303 2.14 (0.50-9.07)
Receiving anti-thymocyte globulin as an induction of immunosuppression (%) Yes 44 (88) 36 (72) - 1
No 6 (12) 14 (28) 0.051 2.85 (0.995-8.173)
Anti-thymocyte globulin dose (mg), median (interquartile range) 375 (300) 310 (300) 0.39 0.99 (0.99-1.001)
Immunosuppressive maintenance regimen (%) Tacrolimus+Mycophenolate+Prednisolone 42 (84) 4 (72) --- 1
Others 8 (16) 46 (28) 0.152 2.042 (0.77-5.42)
Glomerular filtration rate at hospital admission (mL/min, median+interquartile range) 7.5±0.0 8.4±0.25 0.19 1.06 (0.97-1.16)
Cyclosporine trough level (ng/dL, mean±SD) 711.873±184.1 422.41±149.62 0.37 0.99 (0.98-1.007)
Tacrolimus trough level (ng/dL, mean±SD) 7.45±3.18 5.56±2.12 0.01 0.76 (0.61-0.95)
Delayed graft function (%) Yes 7 (14) 4 (8) --- 1
No 43 (86) 46 (92) -0.343 1.87 (0.51-6.85)

SD: Standard deviation; OR: Odds ratio; A univariate logistic regression analysis was used.